17.06.2013 Views

EAU 2013 - Programme Book - YouMed

EAU 2013 - Programme Book - YouMed

EAU 2013 - Programme Book - YouMed

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Monday, 18 March - <strong>EAU</strong> <strong>Programme</strong><br />

Abstract Session<br />

09.15 - 10.45 OAB in women<br />

Blue Hall 1-2 - Level N1<br />

Poster Session 64<br />

Chairs: P. Dinis Oliveira, Porto (PT)<br />

T. Hanus, Prague (CZ)<br />

Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes<br />

in length, followed by 2 minutes for discussion. Extended presentations (*) are 4 minutes in length, followed<br />

by 2 minutes for discussion.<br />

* 775 Sacral Nerve Stimulation (SNS) for the treatment of idiopathic refractory overactive bladder: Costeffectiveness<br />

compared to optimal medical therapy, botulinum toxin A (BoNT-A) and percutaneous tibial<br />

nerve stimulation (PTNS)<br />

J. Jenks, R. Hamid, P.J.R. Shah, T.J. Greenwell, C. Betts, S. Walleser, N. Hallas, J.L. Ockrim (London, Salford,<br />

United Kingdom; Tolochenaz, Switzerland)<br />

776 Tined lead versus percutaneous nerve evaluation for sacral nerve stimulator assessment<br />

J. Jenks, R. Hamid, P.J.R. Shah, T.J. Greenwell, J.L. Ockrim (London, United Kingdom)<br />

777 Affect on bowel symptoms in patients having sacral neuromodulation for detrusor overactivity<br />

A. Gulamhusein, J. Fielding, R. Simmons, S.V. Reid (Sheffield, United Kingdom)<br />

778 Transcutaneous posterior tibial nerve stimulation: Evaluation of therapeutic option in overactive bladder<br />

syndrom<br />

M. Ammi, P. Bigot, D. Chautard, S. Larre, T. Culty, C. Pinon, A. Azzouzi (Angers, France)<br />

779 Objective efficacy of mirabegron on storage and voiding function in patients with overactive bladder,<br />

based on a urodynamic study<br />

Y. Matsukawa, Y. Funahashi, S. Takai, Y. Yoshino, T. Yamamoto, M. Gotoh (Nagoya, Japan)<br />

* 780 Overactive bladder syndrome in elderly: Is there a place for detrusor Botox injections?<br />

V.M. Keppenne, D. Waltregny, S. Sanjurjo (Liege, Belgium)<br />

781 Discontinuation rates and inter-injection interval for repeated intravesical botulinum toxin type A<br />

injections in detrusor overactivity<br />

R. Veeratterapillay, C. Harding, N. Vasdev, L. Teo, A. Abroaf, R. Pickard, T. Dorkin, T. Hasan, A. Thorpe<br />

(Newcastle upon Tyne, United Kingdom)<br />

782 The effect of solifenacin on bladder wall thickness in women with overactive bladder and detrusor<br />

overactivity: Results from the SHRINK study<br />

D. Robinson, M. Oelke, R. Tretter, B. Stow, G. Compion, A. Tubaro (London, Chertsey, United Kingdom;<br />

Hanover, Germany; Leiderdorp, The Netherlands; Rome, Italy)<br />

783 Single surgeon experience of clam ileocystoplasty for refractory idiopathic detrusor overactivity<br />

S. Pisipati, F. Khan, R.B. Kinder (Cheltenham, United Kingdom)<br />

784 The characteristics and prognosis for impaired detrusor contractility in non-geriatric patients<br />

C-W. Yang, Y-H. Fan, C-C. Lin, J.S. Huang, T.L. Ling, K-K. Chen (Taipei, Taiwan)<br />

<strong>EAU</strong> Milan <strong>2013</strong><br />

251<br />

Monday

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!